GKOS
Price:
$130.68
Market Cap:
$7.68B
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to...[Read more]
Industry
Medical - Devices
IPO Date
2015-06-25
Stock Exchange
NYSE
Ticker
GKOS
According to Glaukos Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 5.43. This represents a change of 4.33% compared to the average of 5.21 of the last 4 quarters.
The mean historical Current Ratio of Glaukos Corporation over the last ten years is 6.23. The current 5.43 Current Ratio has changed 8.62% with respect to the historical average. Over the past ten years (40 quarters), GKOS's Current Ratio was at its highest in in the September 2020 quarter at 9.73. The Current Ratio was at its lowest in in the June 2021 quarter at 1.40.
Average
6.23
Median
5.90
Minimum
4.56
Maximum
9.45
Discovering the peaks and valleys of Glaukos Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.31%
Maximum Annual Current Ratio = 9.45
Minimum Annual Increase = -21.67%
Minimum Annual Current Ratio = 4.56
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.69 | -21.67% |
| 2024 | 5.99 | 12.06% |
| 2023 | 5.34 | -12.90% |
| 2022 | 6.13 | -20.05% |
| 2021 | 7.67 | -18.77% |
| 2020 | 9.45 | 107.31% |
| 2019 | 4.56 | -21.65% |
| 2018 | 5.81 | 4.22% |
| 2017 | 5.58 | -21.26% |
| 2016 | 7.09 | 38.55% |
The current Current Ratio of Glaukos Corporation (GKOS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.34
5-year avg
5.97
10-year avg
6.23
Glaukos Corporation’s Current Ratio is less than TransMedics Group, Inc. (6.74), greater than iRhythm Technologies, Inc. (5.17), greater than Bausch + Lomb Corporation (1.53), greater than Merit Medical Systems, Inc. (5.08), greater than Bruker Corporation (1.55), greater than Alkermes plc (2.27), greater than Arcellx, Inc. (4.44), greater than Oscar Health, Inc. (1.09), less than Arrowhead Pharmaceuticals, Inc. (6.23), greater than Teleflex Incorporated (2.55),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.74 | $2.72B | |
| 5.17 | $3.44B | |
| 1.53 | $5.30B | |
| 5.08 | $4.01B | |
| 1.55 | $8.71B | |
| 2.27 | $7.50B | |
| 4.44 | $6.73B | |
| 1.09 | $7.36B | |
| 6.23 | $11.52B | |
| 2.55 | $5.62B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glaukos Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Glaukos Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Glaukos Corporation's Current Ratio?
How is the Current Ratio calculated for Glaukos Corporation (GKOS)?
What is the highest Current Ratio for Glaukos Corporation (GKOS)?
What is the 3-year average Current Ratio for Glaukos Corporation (GKOS)?
What is the 5-year average Current Ratio for Glaukos Corporation (GKOS)?
How does the current Current Ratio for Glaukos Corporation (GKOS) compare to its historical average?